Hypertrophic Muscle & Recomposition
GHRH/GHRP stacks versus somatropin. Secretagogues pulse endogenous GH; they are not a hypertrophy NDA.
Full stacking map, tiers, and monitoring notes live on the protocol page — this hub only lists the compounds already named for this goal.
Compounds on this goal
CJC-1295 (no DAC)
gh_secretagogueProvides a powerful baseline elevation of endogenous Growth Hormone, establishing an anabolic, nitrogen-retaining systemic foundation.
Open peptide leaf →Ipamorelin
gh_secretagogueActs synergistically with CJC-1295 to maximize the GH pulse amplitude without triggering the hunger/prolactin side-effects common with GHRP-6.
Open peptide leaf →PEG-MGF
recoveryPegylated Mechano Growth Factor - a specialized IGF-1 splice variant that exclusively activates dormant satellite cells in muscle tissue following mechanical trauma (resistance training).
Open peptide leaf →Evidence note on this goal
Protocol evidence level (from existing goal data): Emerging
- CJC-1295 and Ipamorelin are not FDA-approved; the FDA has expressed concerns about compounded versions
- No randomized controlled trials specifically measure hypertrophy outcomes with this peptide combination
- Most evidence for muscle-building efficacy is extrapolated from the known physiological effects of elevated GH/IGF-1
- PEG-MGF has limited published human data; most studies are in animal models or in vitro